{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:00:24Z","timestamp":1781730024229,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T00:00:00Z","timestamp":1478563200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00259-016-3563-6","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T03:38:12Z","timestamp":1478576292000},"page":"689-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients"],"prefix":"10.1007","volume":"44","author":[{"given":"Mike","family":"Sathekge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thabo","family":"Lengana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Modiselle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariza","family":"Vorster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JanRijn","family":"Zeevaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ebenhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Van de Wiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,8]]},"reference":[{"issue":"1-2","key":"3563_CR1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-4781(98)00200-0","volume":"1443","author":"DS O\u2019Keefe","year":"1998","unstructured":"O\u2019Keefe DS, Su SL, Bacich DJ, Horiguchi Y, Luo Y, Powell CT, et al. Mapping, genomic organization and promotor analysis of the human prostate-specific membrane antigen gene. Biochim Biophys Acta. 1998;1443(1-2):113\u201327.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"3563_CR2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrurol.2016.26","volume":"13","author":"T Maurer","year":"2016","unstructured":"Maurer T, Eiber M, Schwaiger M, Gschwend J. Current use of PSMA-PET in prostate cancer management. Nat Rev Urol. 2016;13(4):226\u201335.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"3563_CR3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eururo.2016.01.029","volume":"70","author":"L Evangelista","year":"2016","unstructured":"Evangelista L, Briganti A, Fanti S, Joniau S, Reske S, Schiavina R, et al. New clinical indications for 18F\/11C-choline, new tracers for positron emission tomography and a promising hybrid device for prostate cancer staging: a systematic review of the literature. Eur Urol. 2016;70(1):161\u201375.","journal-title":"Eur Urol"},{"issue":"4","key":"3563_CR4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2967\/jnumed.115.169243","volume":"57","author":"K Rahbar","year":"2016","unstructured":"Rahbar K, Weckesser M, Huss S, Semjonow A, Breyholz HJ, Schrader AJ, et al. Correlation of intraprostatic tumor extent with 68Ga-PSMA distribution in patients with prostate cancer. J Nucl Med. 2016;57(4):563\u20137.","journal-title":"J Nucl Med"},{"issue":"13","key":"3563_CR5","first-page":"3192","volume":"59","author":"S Chang","year":"1999","unstructured":"Chang S, Reuter V, Heston W, Bander N, Grauer L, Gaudin P. Five different anti-prostate-specific membrane antigen (PSMA) antibodies conform PSMA expression in tumor-associated neovasculature. Cancer Res. 1999;59(13):3192\u20138.","journal-title":"Cancer Res"},{"issue":"9","key":"3563_CR6","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s00259-015-3066-x","volume":"42","author":"M Sathekge","year":"2015","unstructured":"Sathekge M, Modiselle M, Vorster M, Mokgoro N, Nyakale N, Mokaleng B, et al. 68Ga-PSMA imaging of metastatic breast cancer. Eur J Nucl Med Mol Imaging. 2015;42(9):1482\u20133.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"3563_CR7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/apm.12195","volume":"122","author":"AG Wernicke","year":"2014","unstructured":"Wernicke AG, Varma S, Greenwood EA, Christos PJ, Chao KS, Liu H, et al. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. APMIS. 2014;122(6):482\u20139.","journal-title":"APMIS"},{"issue":"1","key":"3563_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1475-2867-14-26","volume":"14","author":"N Nomura","year":"2014","unstructured":"Nomura N, Pastorino S, Jiang P, Lambert G, Crawford JR, Gymnopoulos M, et al. Prostate-specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases. Cancer Cell Int. 2014;14(1):26. doi: 10.1186\/1475-2867-14-26 .","journal-title":"Cancer Cell Int"},{"key":"3563_CR9","doi-asserted-by":"crossref","unstructured":"Ebenhan T, Vorster M, Marjanovic-Painter B, Wagener J, Suthiram J, Modiselle M, et al. Development of a single vial kit solution for radiolabeling of 68Ga-DKFZ-PSMA-11 and its performance in prostate cancer patients. Molecules. 2015;20(8):14860\u201378.","DOI":"10.3390\/molecules200814860"},{"issue":"14","key":"3563_CR10","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1128\/MCB.00084-06","volume":"26","author":"R Conway","year":"2006","unstructured":"Conway R, Petrovic N, Li Z, Heston W, Wu D, Shapiro L. Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signaling transduction. Mol Cell Biol. 2006;26(14):5310\u201324.","journal-title":"Mol Cell Biol"},{"issue":"7","key":"3563_CR11","doi-asserted-by":"crossref","first-page":"e41285","DOI":"10.1371\/journal.pone.0041285","volume":"7","author":"CL Grant","year":"2012","unstructured":"Grant CL, Caromile LA, Ho V, Durrani K, Rahman MM, Claffey KP, et al. Prostate-specific membrane antigen (PSMA) regulates angiogenesis independently of VEGF during ocular neovascularization. PLoS One. 2012;7(7):e41285\u20139.","journal-title":"PLoS One"},{"issue":"3","key":"3563_CR12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1155\/JBB.2005.287","volume":"2005","author":"P Tsui","year":"2005","unstructured":"Tsui P, Rubenstein M, Guinan P. Correlation between PSMA and VEGF expression as markers for LNCaP tumor angiogenesis. J Biomed Biotechnol. 2005;2005(3):287\u201390.","journal-title":"J Biomed Biotechnol"},{"issue":"2","key":"3563_CR13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejca.2013.10.004","volume":"50","author":"G Aurilio","year":"2014","unstructured":"Aurilio G, Disalvatore D, Pruneri G, Bagnardi V, Viale G, Curigliano G, et al. A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases. Eur J Cancer. 2014;50(2):277\u201389.","journal-title":"Eur J Cancer"},{"issue":"3","key":"3563_CR14","first-page":"267","volume":"48","author":"S Vamesu","year":"2007","unstructured":"Vamesu S. Angiogenesis and progesterone receptor status in primary breast cancer patients: an analysis of 158 needle core biopsies. Rom J Morphol Embryol. 2007;48(3):267\u201374.","journal-title":"Rom J Morphol Embryol"},{"issue":"Suppl 1","key":"3563_CR15","doi-asserted-by":"crossref","first-page":"81S","DOI":"10.2967\/jnumed.115.157941","volume":"57","author":"G Gebhart","year":"2016","unstructured":"Gebhart G, Flamen P, De Vries EG, Jhaveri K, Wimana Z. Imaging diagnostic and therapeutic targets: human epidermal growth factor receptor 2. J Nucl Med. 2016;57 Suppl 1:81S\u20138.","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"3563_CR16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2007.2001","volume":"5","author":"DA Podoloff","year":"2007","unstructured":"Podoloff DA, Advani RH, Allred C, Benson 3rd AB, Brown E, Burstein HJ, et al. NCCN task force report: positronemission tomography\/computed tomography scanning in cancer. J Natl Compr Canc Netw. 2007;5 Suppl 1:S1\u201322.","journal-title":"J Natl Compr Canc Netw"},{"issue":"suppl 1","key":"3563_CR17","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1148\/rg.27si075517","volume":"27","author":"EL Rosen","year":"2007","unstructured":"Rosen EL, Eubank WB, Mankoff DA. FDG PET, PET\/CT, and breast cancer imaging. Radiographics. 2007;27 suppl 1:S215\u201329.","journal-title":"Radiographics"},{"issue":"1","key":"3563_CR18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00259-010-1590-2","volume":"38","author":"AM Groves","year":"2011","unstructured":"Groves AM, Shastry M, Rodriguez-Justo M, Malhotra A, Endozo R, Davidson T, et al. 18F-FDG PET and biomarkers for tumor angiogenesis in early breast cancer. Eur J Nucl Med Mol Imaging. 2011;38(1):46\u201352.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"3563_CR19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1200\/JCO.20.2.379","volume":"20","author":"R Bos","year":"2002","unstructured":"Bos R, van der Hoeven JJ, van der Wall E, van der Groep P, van Diest PJ, Comans EF, et al. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol. 2002;20(2):379\u201387.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3563_CR20","first-page":"9","volume":"42","author":"N Avril","year":"2001","unstructured":"Avril N, Menzel M, Dose J, Schelling M, Weber W, J\u00e4nicke F, et al. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med. 2001;42(1):9\u201316.","journal-title":"J Nucl Med"},{"issue":"5","key":"3563_CR21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/JCO.2006.07.8097","volume":"25","author":"MI Milowsky","year":"2007","unstructured":"Milowsky MI, Nanus DM, Kostakoglu L, Sheehan CE, Vallabhajosula S, Goldsmith SJ, et al. Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors. J Clin Oncol. 2007;25(5):540\u20137.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3563_CR22","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2967\/jnumed.116.173757","volume":"57","author":"K Rahbar","year":"2016","unstructured":"Rahbar K, Schmidt M, Heinzel A, Eppard E, Bode A, Yordanova A, et al. Response and tolerability of a single dose of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer: a multicenter retrospective analysis. J Nucl Med. 2016;57(9):1334\u20138.","journal-title":"J Nucl Med"},{"issue":"13","key":"3563_CR23","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1158\/1078-0432.CCR-15-2548","volume":"22","author":"DD Hoff Von","year":"2016","unstructured":"Von Hoff DD, Mita MM, Ramanathan RK, Weiss GJ, Mita AC, LoRusso PM, et al. Phase I study of PSMA-targeted docetaxel-containing nanoparticle BIND-014 in patients with advanced solid tumors. Clin Cancer Res. 2016;22(13):3157\u201363.","journal-title":"Clin Cancer Res"},{"issue":"21","key":"3563_CR24","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285(21):1182\u20136.","journal-title":"N Engl J Med"},{"issue":"1","key":"3563_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-012-1978-8","volume":"71","author":"PM Wilson","year":"2013","unstructured":"Wilson PM, LaBonte MJ, Lenz HJ. Assessing the in vivo efficacy of biologic antiangiogenic therapies. Cancer Chemother Pharmacol. 2013;71(1):1\u201312.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"18","key":"3563_CR26","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1073\/pnas.93.18.9764","volume":"93","author":"M Friedlander","year":"1996","unstructured":"Friedlander M, Theesfeld CL, Sugita M, Fruttiger M, Thomas MA, Chang S, et al. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A. 1996;93(18):9764\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3563_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/bcr2642","volume":"12","author":"D Nielsen","year":"2010","unstructured":"Nielsen D, Andersson M, Andersen J, Kamby C. Antiangiogenic therapy for breast cancer. Breast Cancer Res. 2010;12(5):209. doi: 10.1186\/bcr2642 .","journal-title":"Breast Cancer Res"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3563-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-016-3563-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3563-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T05:16:29Z","timestamp":1601183789000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-016-3563-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,8]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["3563"],"URL":"https:\/\/doi.org\/10.1007\/s00259-016-3563-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,8]]}}}